IGHE and Alzheimer disease: Na et al. demonstrated that IV injected syngeneic and allogeneic BM-derived clonal MSCs (cMSCs) can attenuate the severity of ovalbumin (OVA)-induced murine AD by reducing the infiltration of immune cells and IL-4 expression in the skin lesions and down-regulating the serum IgE level.